Foregen Newsletter — January 4th, 2026 We’ve surpassed our fundraising goal, totaling nearly $63,000 for bioreactor development, as we prepare for Milestone 4—the final preclinical objective. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ …
See More from Foregen